Literature DB >> 22487756

Histologic variants of renal cell carcinoma: does tumor type influence outcome?

Fang-Ming Deng1, Jonathan Melamed.   

Abstract

Each histologic type of renal cell carcinoma (RCC) has different pathologic and clinical parameters; however, the independent role of histologic type in outcome prediction remains contested. Most studies show relevance for outcome of each histologic type when correlated with survival by univariate analysis, whereas few studies show differences in outcome once other key prognostic factors, such as stage and grade, are considered. These studies highlight the challenges to prove outcome relevance. Despite the contested independent value of type for outcome prediction, separation of RCC into types is well accepted and can be substantiated on clinical, pathologic, molecular, and general outcome differences.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22487756     DOI: 10.1016/j.ucl.2012.02.001

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  17 in total

Review 1.  The ineligible patient: how to treat patients not included in clinical studies.

Authors:  Frances J Mao; Brian I Rini
Journal:  World J Urol       Date:  2013-02-24       Impact factor: 4.226

2.  Bilateral Multi-Focal Sporadic Papillary Renal Cell Carcinoma: A Unique Surgical Challenge.

Authors:  Priyadarshan Anand Jategaonkar; Smita Priyadarshan Jategaonkar; Sudeep P Yadav; Satyendranath Mehra
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 3.  Management of Atypical Renal Cell Carcinomas.

Authors:  Bobby C Liaw; Reza Mehrazin; Charles Baker; John P Sfakianos; Che-Kai Tsao
Journal:  Curr Treat Options Oncol       Date:  2017-09-14

4.  Forkhead box J1 expression is upregulated and correlated with prognosis in patients with clear cell renal cell carcinoma.

Authors:  Pingyu Zhu; Yongrui Piao; Xiuzhe Dong; Zhehu Jin
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

5.  Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.

Authors:  Hanan AlSaeid Alshenawy
Journal:  Pathol Oncol Res       Date:  2015-02-25       Impact factor: 3.201

6.  Elevated expression of KIF18A enhances cell proliferation and predicts poor survival in human clear cell renal carcinoma.

Authors:  Q I Chen; Bin Cao; Ning Nan; Y U Wang; X U Zhai; Youfang Li; Tie Chong
Journal:  Exp Ther Med       Date:  2016-05-11       Impact factor: 2.447

7.  TPX2 in human clear cell renal carcinoma: Expression, function and prognostic significance.

Authors:  Q I Chen; Bin Cao; Ning Nan; Y U Wang; X U Zhai; Youfang Li; Tie Chong
Journal:  Oncol Lett       Date:  2016-03-31       Impact factor: 2.967

8.  Accuracy of kidney cancer diagnosis and histological subtype within Canadian cancer registry data.

Authors:  Jeffrey G Himmelman; Jennifer Merrimen; Kara Matheson; Chris Theriault; Lori A Wood
Journal:  Can Urol Assoc J       Date:  2017-09       Impact factor: 1.862

9.  Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Nonmetastatic Renal Cell Carcinoma: A Large, Multicenter Cohort Analysis.

Authors:  Seok-Soo Byun; Eu Chang Hwang; Seok Ho Kang; Sung-Hoo Hong; Jinsoo Chung; Tae Gyun Kwon; Hyeon Hoe Kim; Cheol Kwak; Yong-June Kim; Won Ki Lee
Journal:  Biomed Res Int       Date:  2016-11-06       Impact factor: 3.411

10.  Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells.

Authors:  Anna M Czarnecka; Cezary Szczylik; Zofia F Bielecka; Agata Malinowska; Klaudia K Brodaczewska; Aleksandra Klemba; Claudine Kieda; Paweł Krasowski; Elżbieta Grzesiuk; Jan Piwowarski
Journal:  Cell Biosci       Date:  2017-12-16       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.